22'-Cyclouridine

CAS No. 3736-77-4

22'-Cyclouridine( 22'-Anhydrouridine | O22'-Cyclouridine )

Catalog No. M20581 CAS No. 3736-77-4

22'-Cyclouridine is a research tool for antiviral and anticancer studies.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 37 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    22'-Cyclouridine
  • Note
    Research use only, not for human use.
  • Brief Description
    22'-Cyclouridine is a research tool for antiviral and anticancer studies.
  • Description
    22'-Cyclouridine is a research tool for antiviral and anticancer studies.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    22'-Anhydrouridine | O22'-Cyclouridine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3736-77-4
  • Formula Weight
    226.19
  • Molecular Formula
    C9H10N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:45 mg/mL (198.94 mM)
  • SMILES
    OC[C@H]1O[C@@H]2[C@@H](Oc3nc(=O)ccn23)[C@@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Drabikowska A K Lissowska L Veres Z et al. Inhibitor properties of some 5-substituted uracil acyclonucleosides and 22'-anhydrouridines versus uridine phosphorylase from E. coli and mammalian sources[J]. Biochemical Pharmacology 1987 36(23):4125-4128.
molnova catalog
related products
  • Carboxyatractyloside

    Carboxyatractyloside dipotassium is a toxic natural product, acts as an inhibitor of ADP/ATP carrier, inhibits mitochondrial ADP/ATP transport.

  • KPT-6566

    KPT-6566 is a novel selective covalent pin1 inhibitor KPT-6566 shows an IC50 of 640?nM and a Ki of 625.2 nM for PIN1 PPIase domainand has anti-cancer activity.

  • JNJ-1661010

    JNJ-1661010 is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), shows >100-fold selectivity for FAAH-1 than FAAH-2.